Kaletra combination tablets ( Lopinavir Ritonavir HIV)
What are Kaletra tablets (Lopinavir+Ritonavir combination)?
Kaletra tablets are one of the most effective and popular medicines for the treatment of HIV. They contain two active principles: lopinavir and ritonavir. Those components inhibit the protease of human immunodeficiency virus. By this, Kaletra tablets prevent protein synthesis of the virus and stop the further infection of the cells. The combination of lopinavir and ritonavir has a strong antiviral effect, and also increases the residence time and amount of active substances in the blood plasma.
The US National Medical Base has more than two hundreds researches on the effect and use of this medicine. Studies showed that in 1000 patients who have already failed treatment with other antiviral drugs and developed resistance, combination tablets of lopinavir and ritonavir helped to completely restore the healthy amount of CD4 cells in the blood for 37.2% of patients, to reach the virus suppression rate of 90% after one-year therapy.
Active principles: lopinavir 200 mg, ritonavir 50 mg
Amount: 120 tablets
Maker: AbbVie GK, Tokyo, Japan
- inhibiting HIV virus growth,
- inhibiting HIV protease activity,
- increasing lopinavir blood level,
- increasing CD4 cell in the blood plasma.
How to take
Adults: take 2 tablets 2 times a day or 4 tablets once a day depending on your doctor's prescription.
Children or adults with weight below 40 kg: take 2 tablets 2 times a day.
Your may adjust the dosage according to age and symptoms.
Contraindications: do not use for pregnant or breastfeeding women. Do not use for patients with renal or liver disease or for patients taking colchicine.
If an allergic reaction occurs, patient needs to stop using the medicine and consult with their doctor. If patient is taking any other medication or treatment, they should consult with their doctor in advance.